Computer Assisted Semen Analysis (CASA)
Objective Semen Assessment in Andrology
Computer Assisted Semen Analysis (CASA) is a laboratory-based technology used for the evaluation of semen parameters. Unlike conventional manual semen assessment, CASA utilizes specialized imaging systems and software algorithms to analyze sperm concentration, motility, movement characteristics, and other measurable parameters in a standardized manner.
CASA systems are widely used in andrology laboratories and reproductive medicine centers as part of male fertility evaluation.
At Krishna IVF, CASA forms part of the laboratory assessment process used in the evaluation of male reproductive health and infertility.
Understanding CASA
Semen analysis is one of the primary investigations performed during male fertility assessment. Traditionally, semen evaluation was performed manually using microscopic examination.
Computer Assisted Semen Analysis was developed to improve objectivity, standardization, and reproducibility in semen assessment. The system combines microscopy, digital imaging, and analytical software to evaluate sperm characteristics using predefined laboratory parameters.
CASA may assist in the assessment of:
- • Sperm concentration
- • Sperm motility
- • Progressive motility
- • Sperm movement characteristics
- • Morphological assessment depending on system configuration
- • Additional quantitative sperm parameters
The results are interpreted in conjunction with clinical findings, reproductive history, and other laboratory investigations.
CASA and Male Fertility Evaluation
Male infertility is a multifactorial condition that may involve abnormalities in sperm production, sperm function, hormonal factors, genetic factors, systemic health conditions, or reproductive tract disorders.
CASA provides quantitative information that may assist clinicians and andrology laboratories in evaluating sperm-related factors as part of a broader fertility assessment.
However, semen analysis alone does not fully determine fertility potential. Additional investigations may be required depending on the clinical situation.
Research and Academic Contributions
Krishna IVF introduced CASA technology into its andrology workflow in 2007 and has utilized the system as part of male infertility evaluation and reproductive research activities.
Research associated with CASA-based semen assessment has contributed to academic work involving:
- • Male infertility
- • Sperm DNA fragmentation
- • Sperm chromatin integrity
- • Diabetes-related effects on sperm quality
- • Obesity-related reproductive health factors
- • ICSI outcome-related observations
These studies formed part of the institution’s broader research interests in male reproductive health, reproductive biology, and assisted reproductive technology.
CASA and Sperm DNA Fragmentation
Conventional semen analysis evaluates sperm concentration, motility, and morphology; however, additional factors such as sperm DNA integrity may also influence reproductive outcomes.
Academic work from Krishna IVF has explored relationships between CASA-derived semen parameters, sperm DNA fragmentation assessment, and reproductive treatment outcomes in selected clinical situations.
This reflects the institution’s broader approach of integrating laboratory diagnostics, andrology, embryology, and reproductive medicine research.
Quality Assurance and Laboratory Standards
Reliable semen analysis requires standardization, quality control, and adherence to laboratory protocols.
Krishna IVF participates in external quality assurance programs through the External Quality Assurance Scheme in Reproductive Medicine (EQASRM), which supports laboratory performance assessment and quality monitoring.
Quality assurance programs assist laboratories in maintaining consistency, accuracy, and reproducibility in diagnostic reporting.
Clinical Approach at Krishna IVF
Male fertility evaluation at Krishna IVF may involve semen analysis, CASA-based assessment, clinical examination, hormonal evaluation, sperm DNA fragmentation testing where indicated, and other investigations depending on the clinical situation.
The objective is to support evidence-based assessment of male reproductive health as part of comprehensive fertility evaluation and treatment planning.
CASA forms one component of this broader andrology and reproductive medicine workflow.